1-4 of 4
Authors: Sara T Wester
Journal Article
6807 Evaluation of Tobacco Exposure and Teprotumumab Efficacy: Pooled Results from Acute TED Clinical Trials Open Access
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.1954, https://doi.org/10.1210/jendso/bvae163.1954
Published: 05 October 2024
Journal Article
6822 Proptosis Improvement with Teprotumumab is Independent of Race, Ethnicity, Gender and Age from Three Global Randomized, Double-Masked, Placebo-Controlled Trials of Patients with Acute Thyroid Eye Disease (TED) Open Access
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.2047, https://doi.org/10.1210/jendso/bvae163.2047
Published: 05 October 2024
Journal Article
SAT455 A Randomized, Quadruple-masked, Placebo-controlled, Multicenter Trial To Evaluate The Efficacy And Safety Of Teprotumumab In Patients With Chronic (Inactive/Low CAS) Thyroid Eye Disease Open Access
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.1930, https://doi.org/10.1210/jendso/bvad114.1930
Published: 05 October 2023
Journal Article
OR27-04 Efficacy And Safety Results From The Randomized, Placebo-controlled Multicenter Trial With Teprotumumab In Chronic-Low Clinical Activity Score Thyroid Eye Disease Patients Open Access
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.2055, https://doi.org/10.1210/jendso/bvad114.2055
Published: 05 October 2023
